Clinicopathological characteristics of papillary thyroid carcinoma in children
Main Article Content
Keywords
Abstract
Objective: This study aimed to describe the clinicopathological characteristics of papillary thyroid carcinoma (PTC) in children. Subject and method: Cross-sectional study was implemented on a total of 131 pediatric patients (≤ 18 years) who underwent thyroidectomy and histopathological report with PTC from January 2015 to June 2024 at 108 Military Central Hospital and K3 Hospital were included in this study. Result: Patients aged 15-18 years old accounted for 71%; the female/male ratio was 2.1/1. The rate of the classic subtype was 87.7%. The prevalences of tumors > 10mm, tumors in both lobes, multifocality, extrathyroidal extension, and vascular invasion were 58%, 18.3%, 27.5%, 44.3%, and 19.8%, respectively. The rates of central neck lymph node metastasis (CNM) and lateral neck lymph node metastasis (LNM) are 71.8% and 42.0%, respectively. Patients < 15 years old had higher rates of tumors > 10mm, aggressive subtypes, and LNM than patients aged 15-18 years old. Patients with tumors > 10mm and multifocality had higher rates of extrathyroidal extension, CNM and LNM. Conclusion: Pediatric PTC was mainly found in female patients, 15-18 years old. The patients < 15 years old, tumor size > 10mm, and multifocality showed more aggressive features compared to others.
Article Details
References
2. Bernier MO, Withrow DR, Berrington de Gonzalez A et al (2019) Trends in pediatric thyroid cancer incidence in the United States, 1998-2013. Cancer 125(14): 2497-2505.
3. Al-Qurayshi Z, Hauch A, Srivastav S et al (2016) National Perspective of the Risk, Presentation, and Outcomes of Pediatric Thyroid Cancer. JAMA Otolaryngology- Head & Neck Surgery 142(5): 472-478.
4. Oishi N, Kondo T, Nakazawa T et al (2017) Frequent BRAF V600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan. Endocrine Pathology 28(2): 103-111.
5. Golpanian S, Perez EA, Tashiro J et al (2016) Pediatric papillary thyroid carcinoma: Outcomes and survival predictors in 2504 surgical patients. Pediatric Surgery International 32(3): 201-208.
6. Ngô Quốc Duy (2022) Nghiên cứu kết quả điều trị ung thư tuyến giáp ở trẻ em. Luận án tiến sĩ y học. Đại học Y Hà Nội.
7. Nguyễn Văn Lộc, Trần Ngọc Lương, Phan Hoàng Hiệp (2021) Đặc điểm bệnh học và kết quả sớm phẫu thuật ung thư tuyến giáp biệt hóa ở trẻ em tại Bệnh viện Nội tiết Trung ương. Tạp chí Nhi khoa 14(4), tr. 23-28.
8. Sharma RK, Huang B, Lee JA et al (2021) Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population. Journal of Surgical Research 263: 207-214.
9. Lebbink CA, Links TP, Czarniecka A et al (2022) European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. European Thyroid Journal 11(6): 220146.
10. Jie Y, Ruan J, Cai Y et al (2023) Comparison of ultrasonography and pathology features between children and adolescents with papillary thyroid carcinoma. Heliyon 9(1): 12828.
11. Sugino K, Nagahama M, Kitagawa W et al (2022) Cutoff Age Between Pediatric and Adult Thyroid Differentiated Cancer: Is 18 Years Old Appropriate? Thyroid 32(2): 145-152.
12. Siraj AK, Parvathareddy SK, Annaiyappanaidu P et al (2022) Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma. Frontiers in Endocrinology (Lausanne)13:777345.
13. Yorke E, Melck A, Wiseman SM (2016) Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer. Canidian Journal of Surgery 59(4): 287-288.
14. Shaha AR, Poorten VV, Tuttle RM (2020) Multifocality in papillary thyroid carcinoma-An unresolved controversy. European Journal of Surgical Oncology 46(10 Pt A): 1777-1778.
15. Lee YA, Jung HW, Kim HY et al (2015) Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years. Journal of Clinical Endocrinology & Metabolism 100(4): 1619-1629.